查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908737

臨床試驗支援服務市場規模、佔有率和趨勢分析報告：按階段、服務、申辦者、地區和細分市場預測，2026-2033年

Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases (Phase I, Phase II, Phase III, Phase IV), By Service, By Sponsor, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗支援服務市場概況

全球臨床試驗支援服務市場預計到 2025 年價值 256.2 億美元，預計到 2033 年將達到 470 億美元。

預計從 2026 年到 2033 年，全球檢測市場將以 7.93% 的複合年成長率成長。由於新興經濟體對檢測的需求不斷成長、研發投資不斷擴大以及受託研究機構(CRO) 的數量增加，全球市場預計將迅速擴張。

受專利到期影響，製藥公司的研發投入逐年穩定成長。雖然專利通常有效期為20年，但製藥業現行的製度允許學名藥在10年後進入市場。這促使各公司加大研發投入以加速藥物研發，進而推動了整體市場成長。

臨床試驗支援服務在藥物研發中發揮至關重要的作用，包括試驗設計和臨床試驗執行。這些服務還涵蓋臨床試驗設施的升級改造、臨床實驗藥物的購買和儲存、藥物劑量計算以及試劑盒處理。臨床試驗服務為臨床前基礎設施和研究提供支持，包括臨床試驗中心支持、臨床實驗藥物的採購和儲存、臨床實驗藥物的盲法實施、患者招募、數據核對以及藥物退回核對。

此外，新技術的日益普及正在推動市場成長。大多數資料管理軟體被稱為「臨床資料管理 (CDM)」系統。 CDM 系統對於多中心臨床試驗處理大量資料至關重要。製藥公司使用的 CDM 系統大多是商業軟體，但也存在一些開放原始碼工具。 Oracle Clinical、Clintrial、Oracle Clinical Macro、RAVE 和 eClinical Suite 都是典型的 CDM 工具。維護資料管理活動的審核追蹤對於監管申報至關重要。這些 CDM 工具有助於確保審核追蹤並管理差異。 CDM 活動包括資料收集、病例報告表 (CRF) 註釋、CRF 追蹤、資料庫設計、資料輸入、醫學編碼、資料檢驗、差異管理和資料庫鎖定。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 臨床試驗支持服務市場變數、趨勢與範圍

  • 市場譜系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 研發成本分析
  • 科技趨勢
  • 臨床試驗數量分析（2024 年）
  • 定價分析
  • 關稅和貿易協定的影響分析
  • 價值鏈分析
    • 供應趨勢
    • 需求趨勢
  • 市場分析工具
    • 波特五力分析
    • PESTEL 分析與 SWOT 分析

第4章：臨床試驗支援服務市場：按階段分類的估算與趨勢分析

  • 臨床試驗支援服務市場：按階段分類的波動分析
  • 臨床試驗支援服務市場按階段分類的估算與預測，2021-2033年
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第5章 臨床試驗支援服務市場：按服務類型分類的估算與趨勢分析

  • 臨床試驗支援服務市場：按服務類型分類的波動分析
  • 臨床試驗支援服務市場按服務類型分類的估算與預測，2021-2033年
  • 臨床試驗中心管理
  • 病患招募管理
    • 病患招募及登記服務
    • 患者留存率
    • 其他
  • 資料管理
  • 管理人員
  • IRB
  • 其他

第6章：臨床試驗支援服務市場：依申辦方分類的估算與趨勢分析

  • 臨床試驗支援服務市場：申辦方變化分析
  • 2021-2033年按申辦方分類的臨床試驗支援服務市場估算與預測
  • 製藥和生物製藥公司
  • 醫療設備製造商
  • 其他

第7章 臨床試驗支援服務市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 卡達
    • 阿曼

第8章 競爭情勢

  • 主要參與者的分類
    • Market Leaders
    • Emerging Players
  • 2025年市場估值分析（熱力圖分析）
  • 公司簡介
    • Charles River Laboratories International, Inc.
    • Wuxi Apptec, Inc
    • Iqvia Holdings, Inc
    • Syneos Health, Inc.
    • Eurofins Scientific
    • PPD, Inc.（Pharmaceutical Product Development）
    • Icon Plc
    • Laboratory Corporation of America Holdings（Labcorp）
    • Alcura
    • Parexel International Corporation
Product Code: GVR-4-68039-475-9

Clinical Trials Support Services Market Summary

The global clinical trials support services market size was estimated at USD 25.62 billion in 2025 and is projected to reach USD 47.00 billion by 2033, growing at a CAGR of 7.93% from 2026 to 2033. The global market is projected to expand rapidly due to rising demand for trials in emerging economies, increasing R&D investment, and a growing number of contract research organizations (CROs).

The pharmaceutical firms' (R&D) venture has been steadily growing every year, mainly due to patent expirations. An ordinary patent terminates after 20 years; in the pharmaceutical area, there is an arrangement that provides for the entry of a generic version of the medication into the market following a period of 10 years. Thus, companies are increasing their R&D investments to accelerate the development of drugs, thereby expanding the entire market.

Clinical trials support services are quite useful in the event of a drug, such as assay design and clinical testing. It also covers tasks such as strengthening clinical test locations, securing and storing research medications, calculating drug dosages, and handling kits. Preclinical groundwork and research are supported by clinical test services, which include clinical test site assistance, obtaining & storing study drugs, blinding of drugs for studies, patient recruitment, coordination, and reconciliation of returned medications.

In addition, growing adoption of new technologies has fueled market growth. Many software tools for data management are referred to as "Clinical Data Management" (CDM) systems. Multicentric trials require CDM systems to handle massive volumes of data. The majority of CDM systems used by pharmaceutical companies are commercial, but a few open-source tools are also available. Oracle Clinical, Clintrial, Oracle Clinical, Macro, RAVE, and eClinical Suite are common CDM tools. Maintaining an audit record of data management actions is important in regulatory submissions. These CDM tools help ensure the audit trail and manage discrepancies. The CDM activities include data collection, CRF annotation, CRF tracking, database design, data entry, medical coding, data validation, discrepancy management, and database lock.

Global Clinical Trials Support Services Market Report Segmentation

This report forecasts revenue growth at the regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the clinical trials support services market report based on the phases, service,sponsor and region:

  • Phases Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Trial Site Management
  • Patient Recruitment Management
    • Patient recruitment & Registry Services
    • Patient retention
    • Others
  • Data Management
  • Administrative Staff
  • IRB
  • Others
  • Sponsor Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & biopharmaceutical companies
  • Medical device companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Oman
    • Qatar
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Phases
    • 1.2.2. Service
    • 1.2.3. Sponsor
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Support Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
  • 3.3. R&D Spending Analysis
  • 3.4. Technology Landscape
  • 3.5. Clinical Trial Volume Analysis, 2024
  • 3.6. Pricing Analysis
  • 3.7. Tariff and Trade Agreement Impact Analysis
  • 3.8. Value Chain Analysis
    • 3.8.1. Supply Trends
    • 3.8.2. Demand Trends
  • 3.9. Market Analysis Tools
    • 3.9.1. Porter's Five Force Analysis
    • 3.9.2. PESTEL by SWOT Analysis

Chapter 4. Clinical Trials Support Services Market: Phases Estimates & Trend Analysis

  • 4.1. Clinical Trials Support Services Market, by Phases: Segment Dashboard
  • 4.2. Clinical Trials Support Services Market, by Phases: Movement Analysis
  • 4.3. Clinical Trials Support Services Market Estimates & Forecasts, by Phases, 2021 - 2033 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Trials Support Services Market: Service Estimates & Trend Analysis

  • 5.1. Clinical Trials Support Services Market, by Service: Segment Dashboard
  • 5.2. Clinical Trials Support Services Market, by Service: Movement Analysis
  • 5.3. Clinical Trials Support Services Market Estimates & Forecasts, by Service, 2021 - 2033 (USD Million)
  • 5.4. Clinical Trial Site Management
    • 5.4.1. Clinical Trial Site Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Patient Recruitment Management
    • 5.5.1. Patient Recruitment Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Patient Recruitment & Registry Services
      • 5.5.2.1. Patient Recruitment & Registry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Patient Retention
      • 5.5.3.1. Patient Retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Data Management
    • 5.6.1. Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Administrative Staff
    • 5.7.1. Administrative Staff Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. IRB
    • 5.8.1. IRB Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Trials Support Services Market: Sponsor Estimates & Trend Analysis

  • 6.1. Clinical Trials Support Services Market, by Sponsor: Segment Dashboard
  • 6.2. Clinical Trials Support Services Market, by Sponsor: Movement Analysis
  • 6.3. Clinical Trials Support Services Market Estimates & Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical & Biopharmaceutical Companies
    • 6.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Medical Device Companies
    • 6.5.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Clinical Trials Support Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2025 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. Colombia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Colombia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Qatar
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Oman
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Charles River Laboratories International, Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Wuxi Apptec, Inc
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Iqvia Holdings, Inc
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Syneos Health, Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Eurofins Scientific
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. PPD, Inc. (Pharmaceutical Product Development)
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Icon Plc
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Laboratory Corporation of America Holdings (Labcorp)
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Alcura
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Parexel International Corporation
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiative

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 4 Global Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 6 North America Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 8 North America Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 North America Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 10 U.S. Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 11 U.S. Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 12 U.S. Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 13 Canada Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 14 Canada Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 Canada Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 16 Mexico Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 17 Mexico Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 Mexico Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 19 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 21 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 Europe Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 23 UK Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 24 UK Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 25 UK Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 26 Germany Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 27 Germany Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Germany Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 29 France Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 30 France Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 31 France Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 32 Italy Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 33 Italy Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 Italy Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 35 Spain Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 36 Spain Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 Spain Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 38 Denmark Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 39 Denmark Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 Denmark Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 41 Sweden Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 42 Sweden Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Sweden Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 44 Norway Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 45 Norway Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 46 Norway Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 51 China Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 52 China Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 53 China Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 54 India Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 55 India Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 56 India Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 57 Japan Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 58 Japan Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 59 Japan Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 60 Australia Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 61 Australia Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 62 Australia Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 63 South Korea Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 64 South Korea Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 South Korea Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 66 Thailand Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 67 Thailand Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 68 Thailand Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 69 Latin America Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71 Latin America Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 72 Brazil Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 73 Brazil Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 74 Brazil Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 75 Argentina Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 76 Argentina Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 77 Argentina Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 78 Colombia Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 79 Colombia Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 80 Colombia Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Clinical Trials Support Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 84 South Africa Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 85 South Africa Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 86 South Africa Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 90 UAE Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 91 UAE Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 92 UAE Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 96 Oman Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 97 Oman Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 98 Oman Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 99 Qatar Clinical Trials Support Services Market Estimates and Forecasts, by Phases, 2021 - 2033 (USD Million)
  • Table 100 Qatar Clinical Trials Support Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 101 Qatar Clinical Trials Support Services Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Clinical Trials Support Services Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Clinical Trials Support Services Market: Phases outlook and key takeaways
  • Fig. 20 Clinical Trials Support Services Market: Phases movement analysis
  • Fig. 21 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Clinical Trials Support Services Market: Service outlook and key takeaways
  • Fig. 26 Clinical Trials Support Services Market: Service movement analysis
  • Fig. 27 Clinical Trial Site Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Patient Recruitment Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Patient recruitment & Registry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Patient retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Administrative Staff Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 IRB Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Clinical Trials Support Services Market: Sponsor outlook and key takeaways
  • Fig. 37 Clinical Trials Support Services Market: Sponsor movement analysis
  • Fig. 38 Clinical Trial Site Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 North America Clinical Trials Support Services Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Mexico Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Europe Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Germany Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 France Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Italy Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Spain Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Denmark Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Sweden Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Asia Pacific Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Korea Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Brazil Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Argentina Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Colombia Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 MEA Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 UAE Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Qatar Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Oman Clinical Trials Support Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key company categorization
  • Fig. 101 Service heat map analysis
  • Fig. 102 Strategic framework